Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
August 13, 20218:17 PM CESTLast Updated 10 minutes ago
United States
U.S. FDA authorizes COVID-19 vaccine boosters for the immunocompromised
By Manas Mishra and Michael Erman
2 minute read
Aug 13 (Reuters) - The U.S. Food and Drug Administration has authorized a third dose of COVID-19 vaccines by Pfizer Inc (PFE.N)-BioNTech and Moderna Inc (MRNA.O) for people with compromised immune systems.
The amended emergency use authorization on Thursday paves the way for people who have had an organ transplant, or those with a similar level of weakened immune system, to get an extra dose of the same shot they have initially received. Mixing of mRNA vaccines is permitted for the third shot if their original vaccine is not available.
An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Friday voted to recommend the additional doses, an important step before the policy is implemented.
Patients will not need a prescription or the sign off of a health care provider in order to prove they are immunocompromised and receive the additional dose, according to CDC officials.
"It will be a patient's attestation, and there will be no requirement for proof or prescription or a recommendation from an individual's health care provider," CDC official Dr. Amanda Cohn said, speaking before the Advisory Committee on Immunization Practice vote.
The vulnerable group makes up less than 3% of U.S. adults, Rochelle Walensky, director of the CDC, had said before the authorization.
"After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna vaccines," Janet Woodcock, U.S. FDA's acting commissioner, said in a tweet on Thursday.
Woodcock said that others who are fully vaccinated do not need an additional vaccine dose right now.
The FDA's decision does not apply to people who received the one-dose Johnson & Johnson (JNJ.N) vaccine, the CDC said, because there is not enough data to support additional doses yet.
"We think that at least this is a solution for the very large majority of immunocompromised individuals, and we believe that we'll probably have a solution for the remainder in the not-too-distant future," FDA official Peter Marks told the CDC panel.
The FDA and the CDC are working to ensure that immunocompromised recipients of the J&J vaccine have optimal protection, the CDC said.
A syringe is filled with a dose of Pfizer's coronavirus disease (COVID-19) vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid/File Photo
One of the boxes containing the Moderna COVID-19 vaccine is prepared to be shipped at the McKesson distribution center in Olive Branch, Mississippi, U.S. December 20, 2020. Paul Sancya/Pool via REUTERS
Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse
1/4
One of the boxes containing the Moderna COVID-19 vaccine is prepared to be shipped at the McKesson distribution center in Olive Branch, Mississippi, U.S. December 20, 2020. Paul Sancya/Pool via REUTERS
Dr. David Boulware, an infectious disease doctor at the University of Michigan, backed the FDA decision, noting that many of the people who have been hospitalized after vaccination are immunocompromised.
Boulware said that the plan to let patients attest to their own status may lead to more people receiving the shots than intended.
"If it is left up to the honor system, I think many Americans will suddenly wake up and find themselves immunocompromised enough to get a 3rd dose," he said in an email.
BOOSTERS FOR YOUNG, HEALTHY
Scientists are still divided over the broad use of COVID-19 vaccine boosters among those without underlying problems as benefits of the boosters remain undetermined.
Pfizer has previously said the efficacy of the vaccine it developed with partner BioNTech drops over time. read more
Moderna has also said it sees the eventual need for booster doses, especially since the Delta variant has caused "breakthrough" infections in fully vaccinated people.
Reports of infections among vaccinated people and concerns about diminishing protection have galvanized wealthy nations to distribute booster shots, even as many countries struggle to access first vaccine doses.
The World Health Organization last week called for a moratorium on COVID-19 vaccine booster shots until at least the end of September. read more
Still, Americans have already started getting additional shots, even before the FDA has authorized them. According to the CDC, more than 1.2 million people have already received one or more additional doses of a COVID-19 vaccine already.
Wall Street analysts expect the authorization of a booster dose for a broad population to bolster profits of COVID-19 vaccine makers.
Shares of Pfizer, Moderna and U.S.-listed shares of BioNTech rose between 1% and 2% in early trading.
Reporting by Manas Mishra in Bengaluru; Additional reporting by Bhargav Acharya; Editing by Shounak Dasgupta, Shinjini Ganguli, Aurora Ellis and Nick Zieminski
Our Standards: The Thomson Reuters Trust Principles.
More from Reuters
Canada's PM Trudeau planning snap election
Canada's PM Trudeau planning snap election
Canada's PM Trudeau planning snap election
Barbie celebrates Elvis Presley with new collectable doll
Barbie celebrates Elvis Presley with new collectable doll
Panic buying as Australian capital enters lockdown
Panic buying as Australian capital enters lockdown
Five stories you need to know about today
Five stories you need to know about today
Barbie celebrates Elvis Presley with new collectable doll
Barbie celebrates Elvis Presley with new collectable doll
Cuban diaspora sends medicine to ease shortages
Cuban diaspora sends medicine to ease shortages
South Korea turns COVID testing booth contactless
South Korea turns COVID testing booth contactless
The Jordan Trail: history and culture on foot
The Jordan Trail: history and culture on foot
U.S. sending troops to Kabul airport for safety, security -Pentagon
U.S. sending troops to Kabul airport for safety, security...
Canada's PM Trudeau planning snap election
Canada's PM Trudeau planning snap election
Read Next
Healthcare & Pharmaceuticals
U.S. workplace regulator says vaccinated workers should wear masks
8:26 PM CEST
Healthcare & Pharmaceuticals
U.S. CDC panel recommends use of COVID-19 vaccine boosters in immunocompromised
8:12 PM CEST
United States
U.S. military base in Washington on lockdown due to potential armed individual
8:22 PM CEST
United States
U.S. judge leaves CDC COVID-19 eviction moratorium in place
7:41 PM CEST
Sign up for our newsletter
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
United States
United States · 4:20 PM CEST
Moderate U.S. House Democrats add to division over Biden agenda
Nine moderate Democrats in the U.S. House of Representatives threatened on Friday to withhold support from a $3.5 trillion budget resolution that represents one of President Joe Biden's top priorities, until a $1 trillion bipartisan infrastructure plan is signed into law.
United States
'It's like a war zone' - U.S. Air Force veteran comforts children plagued by gun violence
7:13 PM CEST
United States
U.S. judge leaves CDC COVID-19 eviction moratorium in place
7:41 PM CEST
United States
In U.S. redistricting fight, citizens come armed with a new weapon: their own maps
4:01 PM CEST
United States
In desperation, U.S. scours for countries willing to house Afghan refugees
7:39 PM CEST
Latest
Home
Media
Videos
Pictures
Graphics
Browse
World
Business
Legal
Markets
Breakingviews
Technology
Investigations
Lifestyle
About Reuters
About Reuters
Careers
Reuters News Agency
Brand Attribution Guidelines
Reuters Leadership
Reuters Fact Check
Reuters Diversity Report
Stay Informed
Download the App
Newsletters
Information you can trust
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Follow Us
Thomson Reuters Products
Westlaw
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
Onesource
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
Checkpoint
The industry leader for online information for tax, accounting and finance professionals.
Refinitiv Products
Eikon
Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface.
Refinitiv Data Platform
Access to real-time, reference, and non-real time data in the cloud to power your enterprise.
World-Check
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
Advertise With Us
Advertising Guidelines
Cookies
Terms of Use
Privacy
Corrections
Site Feedback
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All rights reserved